COVID-Infected Trials: Issues Arise In US FDA Reviews, But Nothing Decisive – Yet
• By Michael McCaughan
The COVID storm clouds that darkened clinical trials last year are now starting to rain on applications at the US FDA. • Source: Nielsen Hobbs; the Pink Sheet | Alamy, Getty images
